Find clinical trials for Melanoma in Portland, OR
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Melanoma trials near Portland, OR, USA:
The study is focused on patients with a type of skin cancer known as melanoma. The aim of the study is to see how safe and effective the com...
Phase 3
Portland, Oregon, United States and 109 other locations
study is to determine the objective response of GB1211 and pembrolizumab versus pembrolizumab and placebo in patients with advance metastatic melanoma...
Phase 2
Portland, Oregon, United States
The purpose of this study is compare the response rates in patients with metastatic melanoma treated with high-dose IL-2 to patients treated...
Phase 2
Portland, Oregon, United States
PV-10 in combination with immune checkpoint inhibition. Metastatic melanoma patients (Stage IV or Stage III unresectable, in-transit or sate...
Phase 1, Phase 2
Portland, Oregon, United States and 4 other locations
This is a single arm phase II clinical trial of Ipilimumab and Nivolumab in patients with resected mucosal melanoma. Ipilimumab (1 mg/kg) an...
Phase 2
Portland, Oregon, United States and 6 other locations
and pediatric participants after complete resection of Stage IIB/C melanoma with no evidence of disease (NED) who are at high risk for recur...
Phase 3
Portland, Oregon, United States and 130 other locations
and pembrolizumab improves recurrence free survival (RFS) compared to pembrolizumab alone in participants with complete resection of cutaneous melanoma...
Phase 2
Portland, Oregon, United States and 22 other locations
placebo in participants with surgically resected high-risk Stage II melanoma. Participants in Part 1 will receive either pembrolizumab or pl...
Phase 3
Portland, Oregon, United States and 158 other locations
recommended phase 2 dose versus investigator's choice of treatment in patients with previously treated, unresectable or metastatic cutaneous melanoma...
Phase 3
Portland, Oregon, United States and 70 other locations
The objective of this study is to assess safety and efficacy of BA3071 in solid tumors
Phase 1, Phase 2
Portland, Oregon, United States and 11 other locations
Clinical trials
Research sites
Resources
Legal